Gregory Einhorn is an intellectual property attorney whose practice focuses on biotechnology-related intellectual property and portfolio “life cycle” management, with an emphasis on developing and implementing domestic and international patent filing and portfolio strategies, as well as licensing and due diligence evaluation.  His practice has a heavy emphasis in the biotechnology, pharmaceutical and medical device industries, including strategic counseling and comprehensive patent portfolio management for small, medium and large companies.  Dr. Einhorn has a wide range of experience in the life sciences, with expertise in immunology, molecular biology, diagnostics, therapeutics, virology, drug delivery systems, high throughput screening, microarray technology, gene therapy, stem cell biology, liposomal technology, small molecules, proteomics, cleantech, biotech, bioinformatics, nanotechnology and medical devices.   Recent awards include election as a “Superlawyer” (see superlawyers.com) in the San Diego intellectual property category for three consecutive years 2007, 2008 and 2009. Mr. Einhorn is an “of counsel” attorney with Gavrilovich, Dodd & Lindsey, LLP.